BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Massaro C, Min W, Pegtel DM, Baglio SR. Harnessing EV communication to restore antitumor immunity. Adv Drug Deliv Rev 2021;176:113838. [PMID: 34144088 DOI: 10.1016/j.addr.2021.113838] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Soroczynska K, Zareba L, Dlugolecka M, Czystowska-Kuzmicz M. Immunosuppressive Extracellular Vesicles as a Linking Factor in the Development of Tumor and Endometriotic Lesions in the Gynecologic Tract. Cells 2022;11:1483. [PMID: 35563789 DOI: 10.3390/cells11091483] [Reference Citation Analysis]
2 Panvongsa W, Pegtel DM, Voortman J. More than a Bubble: Extracellular Vesicle microRNAs in Head and Neck Squamous Cell Carcinoma. Cancers (Basel) 2022;14:1160. [PMID: 35267467 DOI: 10.3390/cancers14051160] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
3 Liu J, Peng X, Yang S, Li X, Huang M, Wei S, Zhang S, He G, Zheng H, Fan Q, Yang L, Li H. Extracellular vesicle PD-L1 in reshaping tumor immune microenvironment: biological function and potential therapy strategies. Cell Commun Signal 2022;20. [DOI: 10.1186/s12964-021-00816-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
4 Yang P, Peng Y, Feng Y, Xu Z, Feng P, Cao J, Chen Y, Chen X, Cao X, Yang Y, Jie J. Immune Cell-Derived Extracellular Vesicles – New Strategies in Cancer Immunotherapy. Front Immunol 2021;12:771551. [DOI: 10.3389/fimmu.2021.771551] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
5 van Niel G, Gazeau F, Wilhelm C, Silva AKA. Technological and translational challenges for extracellular vesicle in therapy and diagnosis. Adv Drug Deliv Rev 2021;179:114026. [PMID: 34710528 DOI: 10.1016/j.addr.2021.114026] [Reference Citation Analysis]